CHORUS AVIATION INC (CHR.CA) Stock Fundamental Analysis
TSX:CHR - Toronto Stock Exchange - CA17040T8885 - Common Stock - Currency: CAD
Overall CHR gets a fundamental rating of 5 out of 10. We evaluated CHR against 9 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR get a neutral evaluation. Nothing too spectacular is happening here. CHR has a bad growth rate and is valued cheaply. This makes CHR very considerable for value investing!
1. Profitability
1.1 Basic Checks
CHR had positive earnings in the past year.
CHR had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHR reported negative net income in multiple years.
Each year in the past 5 years CHR had a positive operating cash flow.
1.2 Ratios
CHR's Return On Assets of -17.42% is in line compared to the rest of the industry. CHR outperforms 44.44% of its industry peers.
CHR has a Return On Equity (-47.80%) which is comparable to the rest of the industry.
With an excellent Return On Invested Capital value of 6.29%, CHR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHR is in line with the industry average of 5.51%.
The 3 year average ROIC (5.30%) for CHR is below the current ROIC(6.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROIC | 6.29% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
1.3 Margins
CHR's Operating Margin of 6.77% is fine compared to the rest of the industry. CHR outperforms 66.67% of its industry peers.
CHR's Operating Margin has declined in the last couple of years.
The Gross Margin of CHR (65.04%) is better than 100.00% of its industry peers.
In the last couple of years the Gross Margin of CHR has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% |
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
2. Health
2.1 Basic Checks
CHR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
CHR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, CHR has more shares outstanding
Compared to 1 year ago, CHR has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.83, we must say that CHR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CHR (0.83) is worse than 66.67% of its industry peers.
CHR has a debt to FCF ratio of 3.86. This is a good value and a sign of high solvency as CHR would need 3.86 years to pay back of all of its debts.
The Debt to FCF ratio of CHR (3.86) is better than 100.00% of its industry peers.
A Debt/Equity ratio of 0.68 indicates that CHR is somewhat dependend on debt financing.
The Debt to Equity ratio of CHR (0.68) is better than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Altman-Z | 0.83 |
ROIC/WACC0.76
WACC8.28%
2.3 Liquidity
A Current Ratio of 1.22 indicates that CHR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.22, CHR is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
CHR has a Quick Ratio of 1.22. This is a bad value and indicates that CHR is not financially healthy enough and could expect problems in meeting its short term obligations.
CHR has a Quick ratio (0.71) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 |
3. Growth
3.1 Past
CHR shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.14%.
The earnings per share for CHR have been decreasing by -19.03% on average. This is quite bad
Looking at the last year, CHR shows a very negative growth in Revenue. The Revenue has decreased by -14.15% in the last year.
CHR shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.56% yearly.
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
3.2 Future
CHR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.82% yearly.
The Revenue is expected to decrease by -2.83% on average over the next years.
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue Next Year-2.5%
Revenue Next 2Y-2.46%
Revenue Next 3Y-2.83%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.49, CHR is valued correctly.
Based on the Price/Earnings ratio, CHR is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.48, CHR is valued rather cheaply.
CHR is valuated reasonably with a Price/Forward Earnings ratio of 10.15.
Based on the Price/Forward Earnings ratio, CHR is valued cheaper than 88.89% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 34.04. CHR is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.49 | ||
| Fwd PE | 10.15 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHR indicates a rather cheap valuation: CHR is cheaper than 88.89% of the companies listed in the same industry.
CHR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CHR is cheaper than 88.89% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.94 | ||
| EV/EBITDA | 4.79 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.2
PEG (5Y)N/A
EPS Next 2Y16.29%
EPS Next 3Y8.82%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.53%, CHR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.71, CHR has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.39, CHR is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.53% |
5.2 History
On average, the dividend of CHR grows each year by 21.58%, which is quite nice.
CHR has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
CHR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
The dividend of CHR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-7.29%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
TSX:CHR (8/8/2025, 7:00:00 PM)
20.73
-0.25 (-1.19%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)
Earnings (Next)
Inst Owners2.5%
Inst Owner ChangeN/A
Ins Owners1.32%
Ins Owner ChangeN/A
Market Cap535.87M
Analysts78.18
Price Target28.67 (38.3%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.53% |
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-7.29%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.69%
Min EPS beat(2)3.87%
Max EPS beat(2)25.51%
EPS beat(4)3
Avg EPS beat(4)39.29%
Min EPS beat(4)-80.2%
Max EPS beat(4)207.96%
EPS beat(8)4
Avg EPS beat(8)7.83%
EPS beat(12)5
Avg EPS beat(12)1.78%
EPS beat(16)7
Avg EPS beat(16)0.15%
Revenue beat(2)0
Avg Revenue beat(2)-3.86%
Min Revenue beat(2)-3.95%
Max Revenue beat(2)-3.78%
Revenue beat(4)0
Avg Revenue beat(4)-6.49%
Min Revenue beat(4)-10.27%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-1.85%
Revenue beat(12)5
Avg Revenue beat(12)-1.08%
Revenue beat(16)9
Avg Revenue beat(16)6.44%
PT rev (1m)1.55%
PT rev (3m)4.79%
EPS NQ rev (1m)0%
EPS NQ rev (3m)8.7%
EPS NY rev (1m)0%
EPS NY rev (3m)8.79%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.49 | ||
| Fwd PE | 10.15 | ||
| P/S | 0.38 | ||
| P/FCF | 4.94 | ||
| P/OCF | 3.59 | ||
| P/B | 1.04 | ||
| P/tB | 1.06 | ||
| EV/EBITDA | 4.79 |
EPS(TTM)1.66
EY8.01%
EPS(NY)2.04
Fwd EY9.85%
FCF(TTM)4.2
FCFY20.25%
OCF(TTM)5.78
OCFY27.89%
SpS53.95
BVpS19.97
TBVpS19.63
PEG (NY)0.2
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -17.42% | ||
| ROE | -47.8% | ||
| ROCE | 8.48% | ||
| ROIC | 6.29% | ||
| ROICexc | 6.74% | ||
| ROICexgc | 6.8% | ||
| OM | 6.77% | ||
| PM (TTM) | N/A | ||
| GM | 65.04% | ||
| FCFM | 7.78% |
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score6
Asset Turnover0.98
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | 3.86 | ||
| Debt/EBITDA | 1.9 | ||
| Cap/Depr | 45.9% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 1.46 | ||
| Cash Conversion | 81.41% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.22 | ||
| Quick Ratio | 0.71 | ||
| Altman-Z | 0.83 |
F-Score6
WACC8.28%
ROIC/WACC0.76
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.14%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%35.71%
EPS Next Y62.27%
EPS Next 2Y16.29%
EPS Next 3Y8.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.15%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-18.31%
Revenue Next Year-2.5%
Revenue Next 2Y-2.46%
Revenue Next 3Y-2.83%
Revenue Next 5YN/A
EBIT growth 1Y-59.15%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year88.24%
EBIT Next 3Y15.21%
EBIT Next 5YN/A
FCF growth 1Y-55.84%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-51.04%
OCF growth 3Y12.73%
OCF growth 5Y0.25%